More Cyclopharm Limited news
Cyclopharm LimitedASX: CYC

Cyclopharm - 2024 First Half Results & USA Expansion Update

Sep 2, 2024 at 11:29 PM EDT · Issued by Cyclopharm Limited

Filed with ASX · Sep 2, 2024 at 11:29 PM EDT

On 6ix: 6ix.com/news/cyclopharm-2024-first-half-results-and-usa-expansion-update

Cyclopharm Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Cyclopharm Limited on 6ix

Story so far

  • Half Year AccountsAug 22, 2023
  • Cyclopharm 2023 Half Year Accounts Update - Record RevenuesJul 17, 2023
  • Half Year 2022 ResultsAug 17, 2022

Earlier from Cyclopharm

  • Cyclopharm 2024 H1 Trading and USA Expansion UpdateAug 26, 2024
  • Cyclopharm completes oversubscribed Share Purchase PlanJun 24, 2024
  • USA Reimbursement Update for TECHNEGASJun 23, 2024
  • Cyclopharm Presenting at Macquarie Emerging Leaders ConfJun 18, 2024
  • TECHNEGAS Awarded US Pass-Through Reimbursemt StatusJun 5, 2024

Later from Cyclopharm

  • CYC Signs Agreement with VA and First DoD Order ReceivedOct 3, 2024
  • CYC Receives First Technegas Orders from US VA HospitalsNov 27, 2024
  • First Patients Imaged with Technegas - French Clinical TrialDec 2, 2024
  • US Clinical Paper - Technegas for Lung Transplant EvaluationDec 8, 2024
  • Cyclopharm's USA Technegas Expansion UpdateDec 20, 2024
All Cyclopharm news releases↗

Follow Cyclopharm into a list and get an email when it puts out news.

Follow Cyclopharm
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer